Generic Medicines Working Group identifies priorities

Four policy priorities that will safeguard affordable access to medicines in Australia while ensuring the generic and biosimilar medicines industry remains viable have been agreed to by the Federal Government. The Generic Medicines Working Group, which was established under the Strategic Agreement signed by the Minister for Heath, Sussan Ley, and the Generic and Biosimilar

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Why upscheduling codeine combination products is a really bad idea
Next New Board of Directors for ASMI